ArticleJournal of thoracic disease2019

A phase II study of concurrent nab-paclitaxel/carboplatin combined with thoracic radiotherapy in locally advanced squamous cell lung cancer.

Kan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.